Advanced search
Publication Cover
Expert Opinion on Therapeutic Targets Volume 18, 2014 - Issue 7
Submit an article Journal homepage
478
Views
12
CrossRef citations to date
0
Altmetric
Reviews

Lipoprotein(a) as a therapeutic target in cardiovascular disease

Marlys KoschinskyChemistry and Biochemistry, University of Windsor, Room 242 Essex Hall, 401 Sunset Avenue, Windsor, Ontario, N9B 3P4, [email protected]
&
Michael BoffaChemistry and Biochemistry, University of Windsor, Room 242 Essex Hall, 401 Sunset Avenue, Windsor, Ontario, N9B 3P4, [email protected]
Pages 747-757 | Published online: 22 May 2014

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Zohaib Iqbal, Shaishav Dhage, Jamal Basheer Mohamad, Alaa Abdel-Razik, Rachelle Donn, Rayaz Malik, Jan Hoong Ho, Yifen Liu, Safwaan Adam, Basil Isa, Claudia Stefanutti & Handrean Soran. (2019) Efficacy and safety of PCSK9 monoclonal antibodies. Expert Opinion on Drug Safety 18:12, pages 1191-1201.
Read now
Michael M Page & Gerald F Watts. (2015) Emerging PCSK9 inhibitors for treating dyslipidaemia: buttressing the gaps in coronary prevention. Expert Opinion on Emerging Drugs 20:2, pages 299-312.
Read now

Articles from other publishers (10)

Joaquim A. Meireles Brandão, Lúcia R. Meireles-Brandão, Rui Coelho & Francisco Rocha-Gonçalves. (2019) Lipoprotein(a) as a key target in combined therapeutic approaches for cardiovascular disease. Revista Portuguesa de Cardiologia (English Edition) 38:7, pages 485-493.
Crossref
Joaquim A. Meireles Brandão, Lúcia R. Meireles-Brandão, Rui Coelho & Francisco Rocha-Gonçalves. (2019) Lipoprotein(a) as a key target in combined therapeutic approaches for cardiovascular disease. Revista Portuguesa de Cardiologia 38:7, pages 485-493.
Crossref
Anthony King. (2018) A CRISPR edit for heart disease. Nature 555:7695, pages S23-S25.
Crossref
Michael M. Page & Gerald F. Watts. (2017) PCSK 9 in context: A contemporary review of an important biological target for the prevention and treatment of atherosclerotic cardiovascular disease . Diabetes, Obesity and Metabolism 20:2, pages 270-282.
Crossref
Xiao-Wu Hong, Dong-Mei Wu, Jun Lu, Yuan-Lin Zheng, Wen-Jun Tu & Jing Yan. (2016) Lipoprotein (a) as a Predictor of Early Stroke Recurrence in Acute Ischemic Stroke. Molecular Neurobiology 55:1, pages 718-726.
Crossref
Rocco Romagnuolo, Corey A. Scipione, Santica M. Marcovina, Matthew Gemin, Nabil G. Seidah, Michael B. Boffa & Marlys L. Koschinsky. (2017) Roles of the low density lipoprotein receptor and related receptors in inhibition of lipoprotein(a) internalization by proprotein convertase subtilisin/kexin type 9. PLOS ONE 12:7, pages e0180869.
Crossref
Jing CaoBrian T. SteffenMatthew BudoffWendy S. PostGeorge ThanassoulisBryan KestenbaumJoseph P. McConnellRussell WarnickWeihua GuanMichael Y. Tsai. (2016) Lipoprotein(a) Levels Are Associated With Subclinical Calcific Aortic Valve Disease in White and Black Individuals. Arteriosclerosis, Thrombosis, and Vascular Biology 36:5, pages 1003-1009.
Crossref
Marco Gentile, Gabriella Iannuzzo, Amalia Mattiello, Gennaro Marotta, Arcangelo Iannuzzi, Salvatore Panico & Paolo Rubba. (2016) Association between Lp (a) and atherosclerosis in menopausal women without metabolic syndrome. Biomarkers in Medicine 10:4, pages 397-402.
Crossref
Michael M. Page, Claudia Stefanutti, Allan Sniderman & Gerald F. Watts. (2015) Recent advances in the understanding and care of familial hypercholesterolaemia: significance of the biology and therapeutic regulation of proprotein convertase subtilisin/kexin type 9. Clinical Science 129:1, pages 63-79.
Crossref
Alexander Sorokin & Kazuhiko Kotani. (2015) Lipoprotein(a) and Arterial Stiffness Parameters. Pulse 3:2, pages 148-152.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.